Anxiety Disease

BASICS

DESCRIPTION
A common acute or chronic, fearful emotion with associated physical symptoms. DSM-IV-R recognizes the following sub types:
  • Acute situational anxiety: Response to recent stressful event, usually transient symptoms
  • Adjustment disorder with anxious mood: Persistent, maladaptive reaction following psychosocial stress and lasting up to six months
  • Generalized anxiety disorder: Persistent underlying anxiety or adjustment disorder with anxious mood and significant symptoms of motor tension, autonomic hyperactivity and hypervigilance, lasting more than six months
  • Panic disorder: Recurrent unexpected attacks with at least one attack (or more) associated with persistent concern about additional attacks, worries about implications of the attack (losing control, having a heart attack) or a significant change in behavior related to the attack; often leads to agoraphobia
  • Post-traumatic stress disorder: Recurrent flashbacks or nightmares of catastrophic event by survivors, often associated with panic attacks and major depression
  • Specific phobias: Intense recurrent fear of, and avoidance of, an object or situation
  • Social phobia: Marked and persistent fear and avoidance of performance or social situations in which the person is exposed to unfamiliar people or scrutiny
  • Obsessive-compulsive disorder: Persistent unwanted and disturbing thoughts and recurrent behavioral patterns (i.e., hand washing) which interfere with daily life
  • System(s) affected: Nervous
  • Genetics: Panic disorder - increased concordance in monozygotic versus dizygotic twins
  • Incidence/Prevalence in USA: 40 million (the most common psychiatric disorder in US)
    • 12 month prevalence rate
      • Panic disorder - female 3.2%, male 1.3%
      • Obsessive compulsive disorder - female 2.6-3.1%, male 1.1-2.6%
      • Agoraphobia - female 3.8%, male 1.7%
      • Generalized anxiety disorder - female 4.3%, male 2.0%
      • Social phobia - female 5.2%, male 3.8%
  • Predominant age: Mainly adults, highest prevalence in 20 to 45 year age group
  • Predominant sex: Female > Male (social phobia female 5.27:male 3.87)
SIGNS AND SYMPTOMS
Patterns vary with subtype of anxiety; not all present in each case
  • Unrealistic or excessive anxiety or worry
  • Sense of impending doom
  • Nervousness
  • Instability
  • Tachycardia; palpitations
  • Systolic click murmur
  • Hyperventilation, choking sensation
  • Labile hypertension
  • Sighing respiration
  • Nausea or abdominal distress
  • Paresthesias
  • Diaphoresis
  • Dizziness or syncope
  • Flushing
  • Muscle tension
  • Muscle tension
  • Restlessness
  • Chest tightness, pressure (pseudoangina)
  • Headache, backaches, muscle spasm
CAUSES
  • Panic disorder, social phobia and obsessive compulsive disorder are associated with genetic factors
  • Psychosocial stressors commonly trigger anxiety disorders and may provoke a genetic diathesis
  • Mediated by abnormalities of neurotransmitter systems (serotonin, norepinephrine and gamma-aminobutyric acid [GABA])
RISK FACTORS
  • Social and financial problems
  • Medical illness
  • Family history
  • Lack of social support

DIAGNOSIS

LABORATORY
  • Selective use of laboratory tests, (with minimal to more extensive workup depending on clinical picture). Laboratory tests often normal in anxiety disorders.
  • CBC and urinalysis
  • Sequential serial multiple analysis (SMA-12 panel)
  • Thyroid function studies
Drugs that may alter lab results: SSRIs may raise serum levels of other medications such as coumadin Disorders that may alter lab results: N/A
PATHOLOGICAL FINDINGS
N/A
SPECIAL TESTS
EEG, ECG, etc.
IMAGING
Usually none; chest x-ray possibly
DIAGNOSTIC PROCEDURES
  • Psychologic testing (e.g., Zung's anxiety self-assessment, Hamilton's anxiety scale)
  • DSM-IV based interview

TREATMENT

APPROPRIATE HEALTH CARE

Outpatient

GENERAL MEASURES
  • Should be based on careful workup and identification of etiology and subtype of anxiety disorders
  • Adequate workup
  • Identify co-existent substance abuse
  • Counseling or psychotherapy along with medications
  • Regular exercise program
  • Biofeedback in selected cases
  • Serial office visits
  • Judicious reassurance after other medical disorders ruled out
SURGICAL MEASURES

N/A

ACTIVITY

Fully active

DIET

No special diet

PATIENT EDUCATION
  • For a listing of sources for patient education materials favorably reviewed on this topic, physicians may contact: American Academy of Family Physicians Foundation, P.O. Box 8418, Kansas City, MO 64114, (800)274-2237, ext. 4400
  • National Institute of Mental Health (NIMH) - National Anxiety Awareness Program, 9000 Rockville Pike, Bethesda, MD 20892
  • Anxiety Disorders Association of America - www.adaa.org

FOLLOW UP

PREVENTION/AVOIDANCE

Management of stress, to extent possible, relaxation techniques, meditation

POSSIBLE COMPLICATIONS
  • Impaired social/occupational functioning
  • Drug dependence (benzodiazepines)
  • Cardiac arrhythmias (TCAs)
EXPECTED COURSE AND PROGNOSIS
  • With active treatment, excellent results can often be obtained, especially with short-term anxiety disorders, including panic disorder
  • Obsessive-compulsive disorder, and post-traumatic stress disorder are more difficult to treat, often requiring long-term psychotherapy and medication (combination treatment)

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Depression (commonly)
  • Agoraphobia
  • Alcohol or substance abuse
  • Somatoform disorders
AGE-RELATED FACTORS

Pediatric: Reduced dosage of medications in adolescent
Geriatric: Reduced dosage of medications
Others: N/A

PREGNANCY
  • Benzodiazepines - contraindicated in first-trimester of pregnancy, and with caution later in pregnancy and during lactation. May cause lethargy and weight loss in nursing infants; avoid breast feeding if mother taking benzodiazepines chronically or in high doses.
  • TCAs - some evidence of fetal risk, especially in first trimester
  • SSRIs - taper and discontinue, if possible, in first trimester; may be used later in pregnancy
OTHER NOTES

N/A

ABBREVIATIONS

DSM-IV-R = Diagnostic and Statistical Manual of Mental Disorders. 4th edition
TCA = tricyclic antidepressant
SSRI = selective serotonergic reuptake inhibitor

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.